Optimization of treatment of endometrial hyperplastic processes in the late reproductive period by hysteroscopic сold loop technique
Keywords:endometrial hyperplastic processes, late reproductive age, endometrial curettage, cold loop, hysteroscopy
The aim of the study was to evaluate the effectiveness of various methods of hyperplastic endometrium removing in late reproductive age women.
Materials and methods. In the prospective cohort study 321 women 35–44 year aged with hyperplastic endometrium processes were selected by the continuous sample method. Depending on the method of treatment of this pathology, the patients were divided into two groups: the Ith group included 143 women whom, after hysteroscopic confirmation of the diagnosis, the hyperplastic endometrium was removed using the “cold loop” technique with the further complex scheme of treatment which included therapy by synthetic gestagens, sedative therapy and use of drugs of melatonin (in the presence of disorders of a dream and hypomelatoninemia). The II group included 178 women, whom after hysteroscopic confirmation of the diagnosis, curettage of a cavity of the uterus was performed, the subsequent hormonal therapy by synthetic gestagena was used according to the Clinical protocol “Endometrial Hyperplasia” (the order of the MOH of Ukraine No. 676 from 31.12.2004). The women of both groups did not differ significantly by age, menstrual cycle peculiarities, gynecological, reproductive, somatic anamnesis and complaints.
Results and conclusions. Analisis of the long-term results of endometrial pathology treatment showed that among I-th group women recurrence of hyperplastic endometrium processes was observed several times less often (p <0.05). The author came to the conclusion that the removal of hyperplastic endometrium by the “cold loop” technique allows to significantly reduce the hyperplastic endometrium processes recurrence and newly detected intrauterine pathology level in comparison with endometrial curretage.
- Chepik, O.F. “Morphogenesis of endometrial hyperplastic processes.” Practical oncology 5.1 (2004): 9–15.
- Kuznetsova, I.V. “Possibilities of therapy of endometrial hyperplastic processes.” Difficult patient 8.1–2 (2010): 18–22.
- Chernuha, G.E. “Adenomatous and glandular hyperplasia of the endometrium in the reproductive age (pathogenesis, clinic, treatment). ” Thesis abstract for MD degree. Moscow (1999).
- Tatarchuk, T.F., Kalugina, L.V., Tutchenko T.N. “Hyperplastic processes of the endometrium: what’s new?” Reproductive endocrinology 25.5 (2015): 7–13.
- Order of the MOH of Ukraine No. 676 from 31.12.2004. Clinical protocol “Endometrial hyperplasia.»
- Zaporozhan, V.N., Tatarchuk, T.F., Dubinina, V.G., Kosei, N.V. “Modern diagnostics and treatment of endometrial hyperplastic processes.” Reproductive endocrinology 3.1 (2012): 5–12.
- Korniyenko, S.M. “Hysteroscopy in the diagnosis and treatment of intrauterine pathology in women of late reproductive and premenopausal age.” Pediatrics, Obstetrics and Gynecology 73.4 (2011): 219–22.
- Patent for utility model № 82305. The method of surgical treatment of recurrent endometrial hyperplastic processes. Registered 25.07.2013. By Korniyenko S.M.
- Ørbo, A., Arnes, M., Hancke, C., et al. “Treatment results of endometrial hyperplasia after prospective D‐score classification: a follow‐up study comparing effect of LNG‐IUD and oral progestins versus observation only.” Gynecol Oncol 111 (2008): 68–73.
- Ørbo, A., Arnes, M., Vereide, A.B., Straume, B. “Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel‐impregnated intrauterine system or oral progestogens.” BJOG 123.9 (2016): 1512–9.
- Dubossarskaya, Z.M., Dubossarskaya, Y.A. “Endometrial hyperplasia (clinical lecture).” Women doctor 5 (2009): 22–7.
- Veropotvelyan, P.N., Guzhevskaya, I.V., Veropotvelyan, N.P., Zhabitskaya, L.A. “Hyperplasia of the endometrium – a modern look at the problem.” Medical aspects of women’s health 10.74 (2013): 33–40.
- Dankovich, N.A., Vorobei-Vikhovskaya, V.N. “Causes and forms of infertility. Modern diagnostic and treatment options.” Women’s health 3 (2013): 192–7.
How to Cite
Copyright (c) 2017 С. М. Корнієнко
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.